Research conducted by Sharma et al. in HCC has identified different subpopulations of TAMs characterized by CD163high and folate receptor beta (FOLR2) expression and other clusters of CD163low TAMs characterized by the expression of Osteopontin (SPP1) or Metallothionein 1G (MT1G). This evidence concerns the gene SPP1 and hepatocellular carcinoma.